The National Inhalant Prevention Coalition, with support from the Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institute on Drug Abuse (NIDA), will hold a press conference to focus on the dangers of inhala
The President’s Budget for FY13 has just been released and offers a timely opportunity to review NIDA’s funding priorities for the research we support. To best fulfill our public health mission to “lead the Nation in bringing the power of science to bear on drug abuse and addiction” requires that we focus on those areas likely to produce the greatest return on the public’s investment.
Presents current knowledge on a variety of addiction issues, including nicotine’s affects on brain function; inhalant abuse; genetically-based research and treatment; maternal tobacco use and its effects on children; and a behavior game for young children.
Offers a list prescription drugs commonly abused, including depressants, opioids and morphine derivatives, and stimulants, and provides their common and street names, how they are generally administered, and their potential health effects.
I am pleased to introduce NIDAMED. NIDA's new initiative to provide the medical community with drug abuse-related resources to enhance patient care. Designed with the demands of modern clinical practice in mind, these research-based, drug-use screening tools and resources are intended to help you screen patients efficiently and conduct the followup steps necessary to provide the best in medical care.
The importance of screening your patients for drug use cannot be underestimated: